Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2005
06/15/2005CN1206368C Solid phase nucleic acid detection probe and preparing method thereof
06/15/2005CN1206367C Determination of a section of mycoplasma urealyticum DNA sequence (4) specificity and its use
06/15/2005CN1206366C Determination of man-shaped mycoplasma DNA sequence (2) specificity and its use
06/15/2005CN1206365C Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan
06/15/2005CN1206357C Nucleic acid molecules which code for enzyme with fructosyltransferase activity and use thereof
06/15/2005CN1206356C Breeding of hepatitis A virus Chinese strain and attenuated strain and its complementary DNA sequence
06/15/2005CN1206352C Usage of xylanase for prepn. of foods
06/15/2005CN1206351C Preparing process and application of lysozyme protein
06/14/2005US6906239 Plant preparations
06/14/2005US6906180 Genes encoding several poly(ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith
06/14/2005US6906176 Polypeptide or use in the fibrinolysis, digestion and coagulation
06/14/2005US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor.
06/14/2005US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
06/14/2005US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof
06/14/2005US6905866 Sigma binding region of RNA polymerase and uses thereof
06/14/2005US6905858 Nucleic acid-free thermostable enzymes and methods of production thereof
06/14/2005US6905855 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
06/14/2005US6905848 Comprises oligonucleotide sequences for detection of proteolytic enzymes associated with opening beta-lactam rings of penicillins and cephalosporins in genomes of gram negative bacteria
06/14/2005US6905845 Isolated nucleic acids; allergies sensitivity
06/14/2005US6905844 Human cervical cancer 2 protooncogene and protein encoded therein
06/14/2005US6905842 Modulation signal transduction; isolated nucleic acids; genetic engineering
06/14/2005US6905841 Target portion comprises beta-alanine aminopeptidase activity and marker portion reveals hydrolysis; bioassays; medical diagnosis
06/14/2005US6905840 Double motor mutant assay for antifungal agents
06/14/2005US6905839 Measuring metabolic clearance for the 6 beta - hydroxylation of cortisol in subject as an index cytochrome P450 3A (CYP3A) activity without use of labeled exogenous cortisol
06/14/2005US6905836 Methods for inhibiting the activation of nuclear factor kappaB (NF- kappa B)
06/14/2005US6905832 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP)
06/14/2005US6905831 Real time measurement of cellular responses
06/14/2005US6905830 Tissue analysis and kits therefor
06/14/2005US6905829 Method for detecting hybridized nucleic acid with improved sensitivity
06/14/2005US6905828 Signaling compound for use as diagnostic tools in chromosome analysis
06/14/2005US6905827 By detecting the expression level of one or more genes or surrogates derived therefrom in the patient; diagnostic oligonucleotides ; kits; Systemic lupus erythematosis (SLE) and Rheumatoid Arthritis (RA)
06/14/2005US6905826 Methods and compositions for microarray control
06/14/2005US6905824 Methods for determining organisms not requiring the separation of fixative or excess probe
06/14/2005US6905823 Cellular arrays and methods of detecting and using genetic disorder markers
06/14/2005US6905822 Monitoring mycobacterium oxidation of organosulfur compounds; obtain bacterial nucleotide sequences, detect mutation in preferential gene, monitor reduction in oxidation of organosulfur compounds
06/14/2005US6905821 Method of determining Dihydropyrimidine dehydrogenase gene expression
06/14/2005US6905820 Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/14/2005US6905818 Detection cloning; isolation hybrids; using labels; genetic engineering
06/14/2005US6905817 Screening signal antagonist; glial cell neutrotropic factor; therapy for nervous system disorders
06/14/2005US6905816 Designing microarrays to accurately detect and diagnosis infectious and/or genetic disorders; drug screening
06/14/2005US6905689 Suitable as a standard for the determination of alkaline phosphatase.
06/14/2005US6905670 Exposing eukaryotic organisms to a single fungal pathogen in the presence of at least one candidate compound; identifying a compound that inhibits fungal pathogen in each of eukaryotic organisms
06/14/2005US6905586 DNA and RNA sequencing by nanoscale reading through programmable electrophoresis and nanoelectrode-gated tunneling and dielectric detection
06/14/2005CA2284100C New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
06/14/2005CA2186945C Method for processing mycobacteria
06/14/2005CA2163816C Electrochemical enzyme biosensor
06/11/2005CA2487578A1 Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
06/09/2005WO2005052596A1 A reference solution
06/09/2005WO2005052592A2 Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
06/09/2005WO2005052590A1 High-throughput screening method for integrin antagonist and new peptide screened therefrom
06/09/2005WO2005052589A1 Method for quantitative and semi-quantitative detection of l-phenylalanine, l-tyrosine, l-3, 4-dihydroxyphenylalanine and their corresponding keto-acids
06/09/2005WO2005052585A1 Method for the detection of pathologically modified prion proteins (prpsc)
06/09/2005WO2005052577A1 Method to identify a biomolecular profile
06/09/2005WO2005052576A1 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 6 (kcnk6)
06/09/2005WO2005052548A2 Method for adjusting the quantification range of individual analytes in a multiplexed assay
06/09/2005WO2005052543A2 Affinity domain for analyte sensor
06/09/2005WO2005052194A2 Gene amplification and overexpression in cancer
06/09/2005WO2005052193A2 Methods for determining the degradation state or concentration of nucleic acids
06/09/2005WO2005052192A1 Pancreatitis
06/09/2005WO2005052191A2 Compositions and methods for the diagnosis and treatment of tumor
06/09/2005WO2005052190A1 MARKER Lmx1a SPECIFIC TO DOPAMINE-PRODUCING NEURON
06/09/2005WO2005052189A2 Method for hla typing
06/09/2005WO2005052188A1 Method for the hybridisation of biological macromolecules on double-stranded nucleic acid segments connected to a solid body surface
06/09/2005WO2005052187A1 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
06/09/2005WO2005052186A1 Means and methods for the determination of camp in vitro and in vivo
06/09/2005WO2005052185A1 Detection of no by using guanylyl cyclase and cgmp production as a readout system
06/09/2005WO2005052184A1 Use of isogenic drug-resistant cell lines to determine the sequence of chemotherapeutic drug treatment
06/09/2005WO2005052183A1 Method and composition for stabilizing liquid reagents
06/09/2005WO2005052180A2 Ntrk1 genetic markers associated with progression of alzheimer’s disease
06/09/2005WO2005052159A1 Latent phase viral interleukin-10-(vii-10) and uses thereof
06/09/2005WO2005052156A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer
06/09/2005WO2005052155A1 Nucleic acid primers for detecting serpula lacrymans dry rot fungus, and methods and test kit in which they are used
06/09/2005WO2005052154A1 Method of estimating toxicity of drug
06/09/2005WO2005052147A2 Method of screening for a modulator of cdk4
06/09/2005WO2005052134A2 Ttbks as modifiers of the beta catenin pathway and methods of use
06/09/2005WO2005052133A2 Method and markers for determining the genotype of horned/polled cattle
06/09/2005WO2005052132A2 Mbms as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005052131A2 C140rf35 as modifier of the beta catenin pathway and methods of use
06/09/2005WO2005052128A2 Mrna transfected antigen presenting cells
06/09/2005WO2005052127A2 Real-time detection of nucleic acids and proteins
06/09/2005WO2005052124A2 Modified dna cleaving enzymes and methods of use
06/09/2005WO2005052123A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
06/09/2005WO2005052115A2 Use of parasitic biological agents for diseases prevention and control
06/09/2005WO2005051993A1 Novel muscle growth regulator
06/09/2005WO2005051985A2 Methods for purifying pertussis toxin and peptides useful therefor
06/09/2005WO2005051977A2 Conditional allele system
06/09/2005WO2005051970A2 Highly parallel dna synthesiser based on matrices
06/09/2005WO2005051967A2 Oligonucleotides labeled with a plurality of fluorophores
06/09/2005WO2005051434A1 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
06/09/2005WO2005051413A2 Disease associated genes
06/09/2005WO2005051320A2 Gcks as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005051319A2 Plks as modifiers of the beta catenin pathway and methods of use
06/09/2005WO2005051314A2 Iraks as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005051295A2 Asymmetrically branched polymer conjugates and microarray assays
06/09/2005WO2005035793A3 Cckar markers and haplotypes associated with extreme weight conditions
06/09/2005WO2005033340A3 Methods and kits for hybridizing multiple probe panels to nucleic acid samples
06/09/2005WO2005032473A3 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
06/09/2005WO2005032362A3 Sensor with increaseed biocompatibility
06/09/2005WO2005031003A9 Mutations in wnt-frizzled signaling pathways associated with osteoarthritis
06/09/2005WO2005030970A3 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
1 ... 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 ... 3003